Clear Cell Adenocarcinoma — Trials

Clear Cell Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 150
Recruiting: 79
Ph III recruiting: 9
Growth YoY: −15.8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03641287	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors	terminated	N/A	64	University of WashingtonOTHER	1	Nov 29, 2023	clinicaltrials
NCT00727532	Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer	terminated	N/A	9	Northwestern UniversityOTHER	1	May 3, 2019	clinicaltrials